Camerino, B. and G.M. Sala: Anabolic steroids. Progr. in Drug Research2: 71, 1960.
2.
Desaulles, P.A. : Les hormones anabolisantes du point de vue experimental. Helv. med. Acta27: 479, 1960.
3.
Anabole Hormone—1. Hauptreferat 28te Jahresversammlung der Schweiz. Gesellschaft f. innere Medizin1960; Helvet. med. Acta27: 479-602, 1960.
4.
Everse, J. W. R. and P. A. van Keep, Eds.: Symposium on anabolic steroids. Acta Endocrin.39: suppl. 63, 1962.
5.
Gross, F., Ed.: Protein Metabolism-Influence of Growth Hormone, Anabolic Steroids and Nutrition in Health and Disease. Springer Verlag, Berlin-Gottingen -Heidelberg, 1962.
6.
David, K., E. Dingemanse, J. Freud and E. Laqueur: Uber Kristallinisches maennliches Hormon aus Hoden (Testosteron), Wirksamer als aus Harn oder aus Cholesterin bereitetes Androsteron. Ztschr. f. physiol. Chem.233: 218, 1935.
7.
Kochakian, C.D. : The protein anabolic effects of steroid hormones . Vitamins and Hormones4: 255, 1946.
8.
Wilson, J.D. : Regulation of protein synthesis by androgens and estrogens. In Ref.5, p. 26.
9.
Laron, Z., S. Assa and J. Matoth: Biological, metabolic and growth promoting effects of human growth hormone . Harefuah64: 1, 1963.
10.
Desaulles, P.A. and C. Kraehenbuhl: Differentiation of atcion of various anabolic steroids. In Ref.5, p. 170.
11.
Kassenaar, A.A.H., A. Querido and A. Haak: Effects of anabolic steroids on nucleic acid and protein metabolism. In Ref.5, p. 222.
12.
Mellman, W.J. , A.M. Bongiovanni, M. Garrison and D.D. Steiker: Comparison of fluoxymesterone and methyltestosterone as growth stimulants. Pediatrics28: 525, 1961.
13.
Laron, Z.: Effectiveness of fluoxymesterone on linear growth and weight in children with growth retardation and underweight. Acta Endocrin. 36: 541, 1961.
14.
Laron, Z.: Use of fluoxymesterone in the treatment of growth retardation. Acta Paediat. In press.
15.
Scharer, K. , H. Habich and A. Prader: Wachstumsfoerderung mit neuen anabolen Steroiden. Helvet. med. Acta27: 530, 1960.
16.
Bierich, J.R. , B. Becker and L. Borner: On the prognosis and therapy of constitutional growth disturbances. Xth International Congress ofPaediatrics , Lisbon, Sept. 1962.
17.
Bayley, N., G.S. Gordan and H. Lisser: Long-term experiences with methyltestosterone as a growth stimulant in short immature boys. Pediat. Clin. N. Amer., p. 819, November 1957.
18.
Laron, Z.: Breast development induced by methandrostenolone (Dianabol). J. Clin. Endocrinol. & Metabol.22: 450, 1962.
19.
Laron, Z.: See Ref. 5, p. 398.
20.
Emerson, K. , Jr., J. Muller, A. de Sonza and G. Loutfi: Paradoxical response of metastatic breast cancer to 17 ethyl-19 nortestosterone. Ann. Int. Med.55: 742, 1961.
21.
Prader, A. and R. Illig: Use of anabolic agents in disorders of growth. See Ref. 5, p. 383.
22.
Nowakowski, H. : In discussion, see Ref. 4, p. 105.
James, V.H.T. , J. Landon and V. Wynn: Effect of an anabolic steroid (methandienone) on metabolism of cortisol in the human. J. Endocrinol.25: 211, 1962.
25.
Wynn, V., J. Landon and V.H.T. James: Effect of an anabolic steroid (methandienone) on pituitary-adrenal function in the human. J. Endocrinol.25: 199, 1962.
26.
Rosenberg, I.N., C.S. Ahn and M.L. Mitchell: Effects of anabolic steroids upon circulating thyroid hormones. J. Clin. Endocrinol. & Metabol.22: 612, 1962.
27.
Marquardt, G.H., C.I. Fisher, P. Levy and R.M. Dowben: Effect of anabolic steroids on liver function tests and creatine excretion. J. A. M. A.175: 851, 1961 .
28.
Werner, M., A. Hitz, F. Gloor and H. Tholen: Die Wirkung von Methandrostenolon auf die menschliche Leber. Klin. Wschr.39: 1006, 1961.
29.
Arias, I.M.: The effects of anabolic steroids on liver function. In Ref. 5, p. 434.
30.
Hsia, D.Y., R.M. Dowben, R. Shaw and A. Gross-man: Inhibition of glucuronosyl transferase by progestational agents from serum of pregnant women. 187: 693, 1960.
31.
Prader, A.: The influence of anabolic steroids on growth. In Ref. 4, p. 78.
32.
Lambrechts, A. and R. Jadoul: Influence of norandrostenolone phenylpropionate on growth and balance experiments in children. In Ref. 4, p. 111.
33.
Todd, R.M.: The growth response of premature babies treated with a synthetic steroid (norethandrolone): a controlled study. Abst. No. 321. Xth International Congress ofPaediatrics, Lisbon, Sept. 1962.
34.
Hubble, D. and D.R. Macmillan: A study of growth promotion in children. Arch. Dis. Childhood37: 518, 1962.
35.
Whitelaw, M.J. , S.F. Thomas, W.H. Graham and T.N. Foster: Growth response in gonadal dysgenesis to the anabolic norethandrolone. Am. J. Obst. and Gynec.84: 501, 1962.
36.
Woodford-Williams, E. and D. Webster: An anabolic study with norethandrolone in four elderly underweight males. Brit. Med. J.2: 1447, 1958.
37.
van Wayjen, R.G.A. and G. Buyze: Clinical-pharmacological evaluation of certain anabolic steroids. In Ref. 4, p. 18.
38.
van Nie, R. , E.L. Benedetti and O. Muhlbock: A carcinogenic action of testosterone provoking uterine tumors in mice. Nature192: 1303, 1961 .
39.
Selye, H.: Selective alteration of certain ACTH and glucocorticoid effects by androstene derivatives. Metabolism4: 403, 1955.
40.
Laron, Z. and J.H. Boss: Failure of I9-nor androstenolone phenylpropionate (Durabolin) to prevent the alterations produced by cortisone in the growing bone in rats. Endocrinology69: 608, 1961.
41.
Falliers, C.J. , J. Szentivanyi, L. Tan and S.C. Bukantz: Comparative effect of three antiinflammatory steroids and one anabolic steroid on growth rates of children with asthma. Abstr. No. 230. Xth International Congress ofPaediatrics , Lisbon, Sept. 1962.
42.
Geyer, G. und H. Jesserer: Klinische und experimentelle Untersuchungen uber die Wirkung von Methandrostenolon . Helv. med. Acta27: 514, 1960.
43.
Bierich, J.R. : Effects and side effects of anabolic steroids in children. In Ref. 4, p. 89.
44.
McCracken, B.H. and F.M. Parsons: Use of Nilevar (17 ethyl-19-nortestosterone) to suppress protein catabolism in acute renal failure. Lancet2: 885, 1958.
45.
Blagg, C.R. and F.M. Parsons: The use of norethandrolone in acute renal failure from obstetric causes. Lancet2: 577, 1960.
46.
Gyorup, S. and J.H. Thaysen: The effect of anabolic steroid (Durabolin) in the conservative management of acute renal failure. Acta med. Scand.167: 227, 1960 .
47.
Thaysen, J.H. : Anabolic steroids in the treatment of renal failure. In Ref. 5, p. 450.
48.
Gerber, W. und P. Cottier: Zur Wirkung anabolen Hormone bei Azotämie. Helv. med. Acta27: 539, 1960.
49.
Gautier, E. und O. Tonz: Anaboles Hormon in der Behandlung der Anurie im Kindesalter. Helv. med. Acta27: 535, 1960.
50.
Wadsworth, G.R.: Blood volume of normal women. Blood9: 1205, 1954.
51.
Shahidi, N.T. and L.K. Diamond: Testosterone induced remission in aplastic anemia of both acquired and congenital types. New Eng. J. Med.264: 953, 1961.
52.
Thomas, K.: Uber neue Beobachtungen haematotroper Effekte von Testosteron Derivaten. Klin. Wschr.39: 55, 1961.
53.
Gardner, F.H. and J.C. Pringle, Jr.: Androgens and erythropoiesis II . New Eng. J. Med.264: 103, 1961.
Kennedy, B.J. : Stimulation of erythropoiesis by androgenic hormones. Ann. Int. Med.57: 917, 1962.
56.
de Toni, E.: Treatment of progressive muscular dystrophy in particular with the anabolic steroids. In Ref. 4, p. 175.
57.
Nowakowski, H. : Metabolic studies with anabolic steroids. In Ref. 4, p. 37.
58.
Bierich, J.B. , R. Grüttner and G. Landbeck: Therapeutic effects of anabolic steroids in progressive muscular dystrophy. Abstr. No. 324. Xth International Congress ofPaediatrics, Lisbon, Sept. 1962.
59.
Tolentino, P.: Protein anabolic steroid hormones and antibody formation. Ann. Paediat.199: 467, 1962.
60.
Jeune, M., R. Francois et B. Jarlot: Contribution a l'etude des polycories glycogeniques du foie. Rev. Internat. d'hepatologie9: 1, 1959.
61.
Eberlein, W.R. , B.A. Illingworth and J.B. Sidbury: Heterogeneous glycogen storage disease in siblings and favorable response to synthetic androgen administration . Am. J. Med.33: 20, 1962.
62.
Weber, H. und W. Hagge: Uber eine wirksame Behandlung der Cytinose. Klin. Wschr.40: 702, 1962.
63.
Landon, J., V. Wynn, J.N.C. Cooke and A. Kennedy: Effect of anabolic steroid, methandienone, on carbohydrate metabolism in man . Metabolism11: 501, 1962.
64.
Houtsmuller, A.J.: The therapeutic applications of anabolic steroids in opthalmology. In Ref. 4, p. 154.
65.
Wilkins, L. , H.W. Jones, Jr., G.H. Holman and K.S. Stempfel, Jr.: Masculinization of the female fetus associated with administration of progestins during gestation. J. Clin. Endocrinol. and Metab.18: 559, 1958.
66.
Lamy, M., J Frezal, N. Josso-Muhlstein, J. Rey, A. Lambert et A. Netter: Le danger des traitements hormoneaux en debut de grossesse: un cas de pseudo-hermaphrodisme feminin du au Methandrostenediol. Bull. Gynec. et Obstet.12: 147, 1960.